Southern Belgium’s Leading Healthcare Network Chooses deepcOS ® for Radiology Workflow Optimization

Munich, Germany, November 25, 2025 — Vivalia, one of Southern Belgium’s most prominent hospital networks, has selected deepcOS®, the vendor-neutral AI infrastructure platform by deepc, to power radiology workflow improvements across its imaging centers in Marche-en-Famenne, Libramont, Arlon, and Bastogne. The project, secured through a competitive public tender through deepc’s well-known channel partner, RMS Medical Devices, advances the use of AI to enhance patient care in the BENELUX region.

Accelerating Clinical Impact Across the Region

Vivalia’s deepcOS® adoption will directly support enhanced clinical pathways, including emergency stroke and trauma triage, as well as bone fracture, thorax and breast imaging, helping radiologists identify urgent cases more quickly and allocate resources more effectively. With deepcOS®, the hospital group will gain intelligent worklist prioritization and access to a growing ecosystem of validated AI tools to ensure timely diagnoses where they matter most.

Unified AI Access Across a Multi-System Environment

Operating across multiple PACS and RIS systems, Vivalia faced the challenge of coordinating radiology workflows across diverse infrastructures. deepcOS® bridges thes
gaps with a single integration layer that allows radiologists to interact with best-in-class AI solutions, eliminating the need for multiple vendor integrations and reducing IT complexity.

A Regional Milestone for AI in Healthcare

This deployment marks a major advancement in the digital transformation of healthcare in the BENELUX region.

“Vivalia’s investment in AI is not only a vote of confidence in deepcOS®, but it’s a strong message that radiology in the region is embracing intelligent, scalable infrastructure to improve clinical outcomes,” said Dr. Franz Pfister, CEO of deepc. “We are honored to support Vivalia alongside our local partner, RMS Medical Devices, in this pivotal transition.”

Our mission and partnership are built on delivering real value to hospitals and their patients,” said Olivier Wouters, Business Director at RMS Medical Devices. “Vivalia’s decision to move forward with deepcOS® reflects a shared belief in the potential of AI to transform care delivery — not just in theory, but in daily clinical practice.”